NO891787L - Molekylaere lokkemidler og fremgangsmaate for anvendelse derav. - Google Patents
Molekylaere lokkemidler og fremgangsmaate for anvendelse derav.Info
- Publication number
- NO891787L NO891787L NO89891787A NO891787A NO891787L NO 891787 L NO891787 L NO 891787L NO 89891787 A NO89891787 A NO 89891787A NO 891787 A NO891787 A NO 891787A NO 891787 L NO891787 L NO 891787L
- Authority
- NO
- Norway
- Prior art keywords
- receptor
- agent
- endogenous
- molecular
- retained
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 108020003175 receptors Proteins 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 230000000717 retained effect Effects 0.000 abstract 2
- 108010041397 CD4 Antigens Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000002581 neurotoxin Substances 0.000 abstract 1
- 231100000618 neurotoxin Toxicity 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polyamides (AREA)
- Saccharide Compounds (AREA)
- Developing Agents For Electrophotography (AREA)
- Paper (AREA)
- Battery Electrode And Active Subsutance (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL8368787A IL83687A (en) | 1987-08-30 | 1987-08-30 | Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions |
| PCT/US1988/002991 WO1989001779A1 (en) | 1987-08-30 | 1988-08-30 | Molecular decoyants and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO891787D0 NO891787D0 (no) | 1989-04-28 |
| NO891787L true NO891787L (no) | 1989-06-06 |
Family
ID=11058121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89891787A NO891787L (no) | 1987-08-30 | 1989-04-28 | Molekylaere lokkemidler og fremgangsmaate for anvendelse derav. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5770572A (da) |
| EP (1) | EP0329778B1 (da) |
| JP (1) | JP2791074B2 (da) |
| AT (1) | ATE123224T1 (da) |
| AU (1) | AU2383988A (da) |
| CA (1) | CA1336489C (da) |
| DE (1) | DE3853910T2 (da) |
| DK (1) | DK175596B1 (da) |
| FI (1) | FI100169B (da) |
| IL (1) | IL83687A (da) |
| NO (1) | NO891787L (da) |
| WO (1) | WO1989001779A1 (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989001940A1 (en) * | 1987-09-04 | 1989-03-09 | Biogen, Inc. | Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins |
| EP0318240A3 (en) * | 1987-11-25 | 1990-08-16 | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MINISTRY OF INTERNATIONAL TRADE & INDUSTRY | Peptide, adsorbent, method for production thereof, and method for use thereof |
| US5132402A (en) * | 1987-11-25 | 1992-07-21 | Agency Of Industrial Science And Technology | Adsorbent, method for production thereof, and method for use thereof |
| US6919076B1 (en) * | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
| US7311920B1 (en) | 1999-10-08 | 2007-12-25 | University Of Maryland Biotechnology Institute | Virus coat protein/receptor chimeras and methods of use |
| US6908612B2 (en) | 1999-10-08 | 2005-06-21 | University Of Maryland Biotechnology Institute | Virus coat protein/receptor chimeras and methods of use |
| ITRM20010563A1 (it) * | 2001-09-14 | 2003-03-14 | Univ Siena | Peptidi antigenici multipli come antidoti nell'intossicazione da veleno di serpente. |
| US8535672B2 (en) | 2002-04-04 | 2013-09-17 | Yissum Research Development Of The Hebrew University Of Jerusalem | Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof |
| RU2005102604A (ru) * | 2002-07-03 | 2005-09-10 | Перикор Сайенс, Инк. (Us) | Композиция гиалуроновой кислоты и способы применения |
| JP4495776B1 (ja) | 2009-07-30 | 2010-07-07 | 日本製薬株式会社 | 融合蛋白質 |
| WO2011119920A2 (en) | 2010-03-25 | 2011-09-29 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
| SMT201800284T1 (it) | 2011-06-10 | 2018-07-17 | Univ Oregon Health & Science | Glicoproteine cmv e vettori ricombinanti |
| EP2568289A3 (en) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
| EP2586461A1 (en) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Viral particles derived from an enveloped virus |
| ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
| EP2848937A1 (en) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Methods of identifying novel HIV-1 immunogens |
| EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
| US20150275231A1 (en) * | 2014-03-31 | 2015-10-01 | Mice With Horns, Llc | Method of Preventing or Reducing Virus Transmission in Animals |
| US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2570278B1 (fr) * | 1984-09-14 | 1987-02-13 | Pasteur Institut | Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise |
| US4761371A (en) * | 1985-02-12 | 1988-08-02 | Genentech, Inc. | Insulin receptor |
| US5126433A (en) * | 1986-08-21 | 1992-06-30 | The Trustees Of Columbia University In The City Of New York | Soluble forms of the t cell surface protein cd4 |
| JP3134874B2 (ja) * | 1986-08-21 | 2001-02-13 | ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク | Ｔ細胞表面タンパク質ｔ４をコードするｄｎａ並びにｔ４フラグメントのａｉｄｓ治療への使用 |
-
1987
- 1987-08-30 IL IL8368787A patent/IL83687A/en not_active IP Right Cessation
-
1988
- 1988-08-30 DE DE3853910T patent/DE3853910T2/de not_active Expired - Fee Related
- 1988-08-30 CA CA000576111A patent/CA1336489C/en not_active Expired - Fee Related
- 1988-08-30 AT AT88908569T patent/ATE123224T1/de not_active IP Right Cessation
- 1988-08-30 US US07/410,778 patent/US5770572A/en not_active Expired - Lifetime
- 1988-08-30 AU AU23839/88A patent/AU2383988A/en not_active Abandoned
- 1988-08-30 WO PCT/US1988/002991 patent/WO1989001779A1/en not_active Ceased
- 1988-08-30 EP EP88908569A patent/EP0329778B1/en not_active Expired - Lifetime
- 1988-08-30 JP JP63507516A patent/JP2791074B2/ja not_active Expired - Fee Related
-
1989
- 1989-04-27 FI FI892005A patent/FI100169B/fi not_active IP Right Cessation
- 1989-04-28 NO NO89891787A patent/NO891787L/no unknown
- 1989-05-01 DK DK198902119A patent/DK175596B1/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE123224T1 (de) | 1995-06-15 |
| FI100169B (fi) | 1997-10-15 |
| DE3853910T2 (de) | 1995-10-12 |
| JPH02502538A (ja) | 1990-08-16 |
| NO891787D0 (no) | 1989-04-28 |
| JP2791074B2 (ja) | 1998-08-27 |
| IL83687A (en) | 1995-03-30 |
| FI892005L (fi) | 1989-04-27 |
| EP0329778A1 (en) | 1989-08-30 |
| AU2383988A (en) | 1989-03-31 |
| US5770572A (en) | 1998-06-23 |
| IL83687A0 (da) | 1988-01-31 |
| DK175596B1 (da) | 2004-12-13 |
| DK211989A (da) | 1989-06-28 |
| EP0329778B1 (en) | 1995-05-31 |
| DE3853910D1 (de) | 1995-07-06 |
| EP0329778A4 (en) | 1990-12-27 |
| WO1989001779A1 (en) | 1989-03-09 |
| CA1336489C (en) | 1995-08-01 |
| DK211989D0 (da) | 1989-05-01 |
| FI892005A0 (fi) | 1989-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO891787D0 (no) | Molekylaere lokkemidler og fremgangsmaate for anvendelse derav. | |
| ATE150616T1 (de) | Verabreichungszusammensetzungen für unkrautvertilgungsmittel sowie verfahren zur regelung der pflanzenbevölkerung in wässriger und sumpfähnlicher umgebung | |
| BR0011000A (pt) | Métodos para prevenir ou tratar uma doença associada com depósitos amilóides de ab no cérebro de um paciente, para avaliar um anticorpo quanto á atividade de remoção de uma entidade biológica fisicamente associada com um antìgeno e para detectara um depósito amilóide em um paciente, composição farmacêutica, e, conjunto de diagnóstico | |
| DK0600866T3 (da) | Præparater og fremgangsmåder til identifikation af biologisk aktive molekyler | |
| ATE126441T1 (de) | Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen. | |
| NO162103C (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
| ES2124702T3 (es) | Usos terapeuticos de compuestos que se unen a actina. | |
| EA200100573A1 (ru) | Применение ингибитора циклооксигеназы-2, ингибитора матричной металлопротеиназы, противоопухолевого лекарственного средства и факультативно облучения в качестве комбинированного способа лечения неоплазии | |
| BR0008188A (pt) | Inibidores de fator de diferenciação de crescimento e usos para os mesmos | |
| NO902446L (no) | Dyrefor og fremgangsmaater for deres fremstilling. | |
| DE69820265D1 (de) | Für den vogelembryo geeignete multivalente impfstoffe | |
| YU87090A (sh) | Postupak za prečišćavanje himopapaina | |
| DE3877547D1 (de) | Basisches protein phospholipase a2 aus dem gift der schlangen aus der familie der elapiden, deren aminosaeuresequenz, derivate und fragmente dieses proteins, verfahren um es zu erhalten, therapeutische kompositionen und diagnosemittel, alle dieses protein enthaltend und/oder dessen derivate und/oder dessen fragmente. | |
| DK0517986T3 (da) | Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater | |
| DK345889A (da) | Anvendelse af 5-ht-3-receptorantagonist | |
| Kabanov | Synthetic membrane active polyelectrolytes in design of artificial immunogens and vaccines | |
| DK0544760T3 (da) | Farmaceutiske præparater indeholdende 5-difluormethoxy-2- (3,4-dimethoxy-2-pyridyl)methylsulfinyl benzimidazol og at anti-helicobactermiddel til behandling af gastrointestinale lidelser | |
| DE69638145D1 (de) | Verfahren zur herbeiführung einer immuntoleranz mit hilfe von immuntoxinen | |
| BR9808424A (pt) | Composto, processos para a preparação do mesmo, para a preparação dos intermediários e para tratamento de um mamìfero, incluindo o ser humano, composição farmacêutica, e, uso de um composto. | |
| Sandberg et al. | Inflammatogenic and adjuvant properties of HEMA in mice | |
| DE69007374D1 (de) | Injektionssystem für die Behandlung von Zellen. | |
| NO173336C (no) | Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein | |
| DK0653939T3 (da) | Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner | |
| BR0314711A (pt) | Composições sinérgicas para a prevenção e tratamento da sìndrome da imunodeficiência adquirida | |
| DK0480391T3 (da) | Emulgatorfrie emulsionspolymerer, deres fremstilling og deres anvendelse i farmaceutiske præparater med forlænget frigivelse af virksomt stof |